Artificial intelligence continues to transform how brands create content, analyze information, develop products, and engage customers. From marketing copy and software code to images, videos, and customer communications, AI tools are now deeply embedded in everyday business operations.

At the same time, our courts are being asked to address important legal questions surrounding AI and copyright, namely: “Can AI companies train their models using copyrighted works without permission?” and “What rights exist in content generated by those systems?”

Ludwig, an IP law firm, views these questions as some of the most important IP challenges facing businesses and innovators today. As AI adoption accelerates, we must understand not only the opportunities the technology creates, but also the evolving legal risks surrounding copyright ownership, licensing, and content use.

For businesses that use AI, the answers matter. Ongoing copyright-related lawsuits involving major AI developers, including OpenAI, Meta, Anthropic, and Midjourney, are likely to shape how AI systems are trained, how content is licensed, and how IP rights are enforced for years to come. While many view these cases as disputes between large technology companies and content owners, the eventual outcomes could affect businesses of every size that rely on AI-generated content.

Why AI Copyright Litigation Matters

Copyright law was designed to protect original creative works. AI technologies, however, have introduced entirely new questions about how content is created, used, stored, and reproduced.

Many AI systems are trained using enormous amounts of text, images, music, videos, and other materials gathered from across the internet. Copyright owners have increasingly challenged whether that use requires permission, compensation, or licensing agreements.

The central legal issues extend beyond training data itself. Courts are also examining whether AI-generated outputs may infringe existing copyrights, whether AI companies can rely on fair use defenses, and what ownership rights may exist in AI-generated content.

For businesses investing in AI tools, these questions are no longer theoretical. They directly affect risk management, content strategies, licensing decisions, and IP protection.

Recent Developments in High-Profile Cases

Several high-profile cases are helping shape the legal conversation around AI training, copyright ownership, and IP rights. While the facts and claims differ from case to case, each highlights unresolved questions that could influence how AI technologies are developed, trained, and commercialized in the years ahead.

OpenAI

Perhaps the most closely watched litigation involves The New York Times, authors, and other copyright owners pursuing claims against OpenAI and Microsoft. Plaintiffs allege copyrighted works were used without authorization to train AI systems, while the defendants argue that training constitutes fair use. The case remains closely watched as the parties seek clarification on fundamental copyright and fair-use questions that could influence future AI litigation. A court ruling has not yet been issued, leaving significant legal uncertainty for both AI developers and content owners.

Meta

Meta has faced multiple copyright lawsuits related to its Llama AI models. Authors and publishers have alleged that copyrighted books and written materials were used during AI training without authorization. Some litigation has focused not only on training activities but also on how training materials were acquired.  Meta secured an early fair-use victory related to AI training, but other claims involving the sourcing of training materials remain active. Additional copyright lawsuits brought by publishers and other content owners are still pending.

Anthropic

Anthropic, developer of Claude, has been involved in significant copyright litigation brought by authors concerning books allegedly used in training its AI models. In 2026, a court-approved settlement in Bartz v. Anthropic resolved major claims involving copyrighted books through what has been described as the largest copyright settlement in U.S. history, providing approximately $1.5 billion in compensation covering roughly 482,000 works. Meanwhile, other litigation against Anthropic involving music publishers and copyright owners remains active.

Midjourney

Image-generation platform Midjourney remains at the center of ongoing litigation involving artists, copyright owners, and major entertainment companies. Plaintiffs allege copyrighted images and creative works were used without authorization to train AI systems and generate similar content. Several of these cases remain active.

What These Cases Could Mean for AI-Generated Content

One reason businesses and innovators should pay close attention is that the outcomes of these and other cases may affect both AI developers and AI users.

If courts determine that certain training activities require licenses, AI providers may need to modify training practices, negotiate new licensing agreements, or alter available features. Those costs and operational changes could eventually affect businesses that rely on AI tools.

Questions surrounding ownership also remain important. The U.S. Copyright Office has repeatedly emphasized that copyright generally protects human authorship rather than purely machine-generated works. As businesses increasingly rely on AI-generated text, images, videos, and other content, understanding what rights exist in those outputs becomes increasingly important. Resources such as the NIST Artificial Intelligence Program and the Stanford AI Index can help organizations stay current on developments affecting AI innovation, governance, and intellectual property rights.

Considerations for Businesses Using AI

Ongoing litigation should not be viewed as a reason to abandon AI use. Instead, it highlights the value of thoughtful planning, risk assessment, and ongoing attention to evolving legal developments.

Understand Your AI Tools

Understand which AI systems you use, what terms govern those services, and what protections are available under vendor agreements.

Review Ownership and Usage Rights

Evaluate whether you have appropriate rights to use, modify, publish, or commercialize AI-generated content.

Maintain Human Involvement

Human review and editorial oversight remain valuable not only from a quality standpoint but also when addressing questions involving IP ownership and originality.

Develop Internal AI Policies

Establish clear policies governing employee use of AI tools, approved platforms, content review procedures, and IP considerations.

Monitor Legal Developments

AI-related copyright law continues to evolve rapidly. Those who stay informed will be better positioned to adapt to regulatory and legal changes.

How Ludwig Sees It

Ludwig views these and other related lawsuits as part of a broader shift in how IP law is adapting to emerging technologies. The legal questions being addressed today are likely to influence how organizations develop, license, acquire, commercialize, and protect AI-driven innovations in the future.

Businesses that use AI should not assume that IP risks exist only for technology companies. Organizations that create content, market products, develop software, or leverage AI-generated materials may all encounter copyright-related questions.

The Ludwig team works with businesses, entrepreneurs, innovators, and technology companies to evaluate IP strategies, assess legal risks, protect valuable assets, and navigate emerging technology issues.

Whether you are developing AI-enabled products, implementing generative AI solutions, negotiating licensing agreements, or evaluating copyright exposure, proactive planning is often the best defense.

Frequently Asked Questions

1. Why are AI copyright lawsuits important to businesses?
These cases may influence how AI systems are trained, licensed, and used, potentially affecting businesses that rely on AI-generated content.

2. Which AI companies are involved in major copyright lawsuits?
OpenAI, Meta, Anthropic, and Midjourney are among the companies involved in high-profile copyright litigation.

3. Can businesses own AI-generated content?
Ownership depends on several factors, including the level of human involvement and applicable copyright laws.

4. Should businesses stop using AI because of these lawsuits?
Not necessarily. Most organizations should focus on understanding risks, implementing policies, and maintaining appropriate oversight.

5. How can businesses reduce legal risks when using AI?
Review vendor terms, develop AI usage policies, maintain human review processes, and seek legal guidance when IP questions arise.

Let’s Work Together: Global Experience, Personal Focus

Artificial intelligence presents exciting opportunities, but it also introduces new IP considerations that businesses and innovators cannot afford to ignore. If your organization is using AI tools, developing AI-powered products, or evaluating copyright and IP risks related to emerging technologies, we encourage you to reach out to Ludwig today at (619) 929‑0873 or consultation@ludwigiplaw.com to arrange a free, no‑strings‑attached consultation.

While most recent headlines involving artificial intelligence and intellectual property disputes have focused on copyright claims related to training data, authors, artists, publishers, and content creators, a lawsuit filed in July 2026 has opened a new front: the underlying technology that powers AI systems.

On July 20, 2026, the University of Tennessee Research Foundation (UTRF) filed a patent infringement lawsuit against Claude developer Anthropic in federal court in Delaware, alleging that the company’s AI systems infringe patents related to neuroscience-inspired neural network technology. The case has been widely reported as the first patent infringement lawsuit brought against Anthropic, marking a notable shift in AI litigation from disputes over training data and copyrighted content to claims involving an AI developer’s foundational technology.

Ludwig, an IP law firm, believes this lawsuit could signal the beginning of a new phase in AI-related IP litigation. For companies developing AI products, investors evaluating AI opportunities, universities commercializing research, and patent owners seeking to protect innovation, the case could represent an important shift in how IP disputes unfold in the AI era.

A New Front in the AI/IP Debate

Until recently, many AI-related legal battles centered on a common question: Did AI companies improperly use copyrighted material to train their models? Patent law, however, presents an entirely different issue.

Rather than focusing on what data was used, patent cases typically examine how a technology works. They ask whether a product, process, method, or system falls within the scope of a patented invention.

According to US News & World Report, UTRF alleges that Anthropic’s AI systems infringe two University of Tennessee patents covering “significant contributions to the fields of artificial intelligence, machine learning, neuromorphic computing, and ⁠neuroscience-inspired computing.” The lawsuit seeks monetary damages and an order preventing further infringement. Anthropic has publicly stated that it disagrees with the allegations and intends to defend the case vigorously.

Regardless of the eventual outcome, the lawsuit highlights a growing reality: AI companies may face scrutiny not only for the data they use, but also for the technical architecture that powers their systems.

Why This Case Matters

The significance of this lawsuit extends far beyond one company. For years, universities, research institutions, and private organizations have invested heavily in foundational artificial intelligence research. Many of those innovations resulted in patents that remain active today.

As commercial AI adoption accelerates, patent holders are taking a closer look at whether their inventions are being incorporated, directly or indirectly, into modern AI systems.

This possibility raises important questions:

• How closely are AI companies evaluating the patents surrounding their technologies?
• Are startups conducting sufficient IP due diligence before bringing products to market?
• Have organizations properly documented the origins of technologies incorporated into their products?
• Are licensing rights and ownership chains clear and defensible?

These questions are particularly important because AI innovation often builds on decades of academic and commercial research. The path from laboratory discovery to commercial application can be complex, involving multiple institutions, researchers, funding sources, and licensing agreements.

When ownership histories become unclear, legal disputes frequently follow.

Recent Developments Signal Growing IP Risk

The Anthropic lawsuit arrives at a time when IPy concerns surrounding AI continue to evolve rapidly. Organizations such as the U.S. Patent and Trademark Office have devoted increasing attention to AI-related patent applications and innovation trends.

Useful resources include:

• USPTO Artificial Intelligence Resources: https://www.uspto.gov/artificial-intelligence
• National Institute of Standards and Technology (NIST) AI Resources: https://www.nist.gov/artificial-intelligence
• Stanford University’s AI Index Report: https://aiindex.stanford.edu

The broader trend is clear: AI is maturing from an experimental technology into a mainstream business tool. As markets mature, precedent tells us that IP enforcement often intensifies.

Historically, industries ranging from software and telecommunications to biotechnology experienced significant increases in patent litigation once technologies reached widespread commercial adoption. There is little reason to believe AI will be different. If anything, the economic value associated with AI may increase incentives for patent owners to enforce their rights.

Key Considerations for AI Innovators

Whether you are developing an AI platform, integrating third-party models, or investing in artificial intelligence technologies, now is the time to evaluate your IP exposure.

Understand Your Technology Stack

Many companies focus heavily on product functionality while paying less attention to the underlying technology that makes those capabilities possible. Business leaders should understand where their systems originate, what technologies are incorporated, and whether any critical components may imply third-party IP rights.

Review Licensing Agreements

Organizations should carefully review licenses governing software, research, datasets, development tools, and technical frameworks incorporated into AI systems. A licensing gap discovered early is often far easier and less expensive to address than one discovered during litigation.

Evaluate Patent Risks Proactively

Patent disputes frequently become expensive because organizations wait until a demand letter or lawsuit arrives before evaluating possible exposure. Conducting proactive IP assessments can help identify potential issues before they become significant business risks.

Protect Your Own Innovation

The Anthropic case is a reminder that organizations creating valuable technology should consider whether patent protection may be appropriate. Companies investing heavily in AI development may possess inventions that deserve formal protection. Waiting too long can limit available options.

Document Development Efforts

Maintaining clear records of research, development activities, inventorship, licensing rights, and technology sources can become critically important if ownership questions arise. Good documentation may become one of an organization’s strongest assets during an IP dispute.

How Ludwig Sees It

Ludwig believes the Anthropic lawsuit represents an important signal rather than an isolated event. As AI continues evolving, IP disputes are becoming increasingly sophisticated. Future litigation may focus less on public-facing outputs and more on the technical systems, architectures, methods, and innovations operating behind the scenes.

Organizations developing AI technologies should not assume that innovation alone provides protection. Strong IP strategies require careful planning, ongoing risk assessment, proper documentation, and a clear understanding of both ownership rights and potential exposure.

Ludwig works with innovators, startups, researchers, entrepreneurs, investors, and established businesses to help identify IP risks, develop protection strategies, evaluate licensing opportunities, and navigate emerging technology challenges. Whether you are building an AI-enabled product, evaluating a patent portfolio, negotiating technology rights, or responding to potential infringement concerns, proactive legal guidance can make a significant difference.

Frequently Asked Questions

1. Why is the University of Tennessee lawsuit against Anthropic significant?
The case is believed to be the first major patent infringement lawsuit targeting AI technology rather than focusing on training data or copyright claims.

2. How are patent claims different from AI copyright claims?
Copyright claims generally focus on content used to train AI systems, while patent claims focus on how the underlying technology or processes operate.

3. Should AI startups be concerned about patent infringement risks?
As AI adoption grows, patent owners may increasingly scrutinize products, architectures, and technical methods used by AI companies.

4. What steps can companies take to reduce AI-related IP risks?
Organizations should review licensing agreements, evaluate patent exposure, document development efforts, and conduct regular IP assessments.

5. Can universities enforce patents against AI companies?
Universities and research foundations frequently hold valuable patent portfolios and may pursue licensing agreements or infringement actions when they believe their rights have been violated.

Let’s Work Together: Global Experience, Personal Focus

If your company is developing AI technologies, evaluating patent opportunities, or facing IP questions related to emerging technologies, we encourage you to speak with our team. The organizations that succeed will not only innovate effectively but also understand how to protect and leverage their IP assets. Contact Ludwig at (619) 929‑0873 or consultation@ludwigiplaw.com to arrange a free, no‑strings‑attached consultation.

2026 has not been a quiet year for intellectual property matters. AI adoption, brand protection pressures, patent eligibility battles, and trade secret disputes have all collided to reshape how companies defend and leverage their IP. While no one has a crystal ball, Ludwig is seeing clear signals in this year’s litigation patterns that foreshadow the disputes likely to define 2027.

The real challenge? Many businesses are still operating with 2023‑era assumptions, before widespread adoption of AI fundamentally changed how innovation is created, documented, and protected. Meanwhile, courts and regulators are issuing decisions that redefine IP ownership, enforcement obligations, and what counts as protectable innovation. Companies that don’t recalibrate now risk walking into the future with blind spots.

What’s Been Happening

This year delivered several influential rulings across AI, trademarks, patents, and trade secrets:

• AI & IP Rights: Courts have sharpened expectations around human contribution in AI‑assisted work. Whether it’s copyrightable expression or patentable invention, documentation of human involvement is becoming essential. Cases involving training data and output liability have also pushed companies to rethink how they deploy generative tools.
• Trademarks: The rise of online marketplaces has accelerated the spread of counterfeit goods, pushing brands into more frequent and aggressive trademark enforcement actions. In numerous cases, courts are signaling that passive brand protection is no longer enough. Companies are expected to monitor, act, and demonstrate diligence.
• Patents: Eligibility remains a battleground, especially for inventions involving algorithms, machine learning, biotech processes, and hybrid human‑machine systems. Several decisions this year reinforced that drafting strategy and technical support matter more than ever. Recent 2026 analysis from JD Supra highlights that the USPTO and Federal Circuit continue to reject high‑level algorithmic claims that merely manipulate or compare data without demonstrating a concrete technological improvement.
• Trade Secrets: Remote work, employee mobility, and cross‑border collaboration have created fertile ground for disputes. Courts are scrutinizing whether companies took “reasonable measures” to protect confidential information—and the bar for “reasonable” keeps rising.

Across industries, these rulings are influencing how companies approach innovation, protect assets, and prepare for disputes. The litigation signals are clear 2027 will not be a year for reactive IP strategy. The time to prepare is now.

Actions to Consider

Here are several areas sure to be of interest to IP owners/creators as they prepare for 2027. Consider the following actions:

• AI‑Driven Creation: Review how your organization documents human involvement in AI‑assisted work. Courts are increasingly requiring proof of human contribution to claim ownership.
• Trademark Enforcement: Evaluate whether your monitoring and enforcement practices match current expectations. Registration alone won’t protect your brand.
• Patent Portfolio Strength: Identify patents vulnerable to eligibility challenges. Consider whether your filings align with how courts are currently interpreting technical contribution and inventive concept.
• Trade Secret Protection: Reassess your protocols. Non-disclosure agreements and basic policies are no longer enough. Courts want to see layered, practical, consistently applied measures.
• Cross‑Functional Risk: Product launches, partnerships, acquisitions, and market expansions all carry IP implications. Litigation trends should inform strategic planning, not just legal cleanup.
• Litigation Readiness: Even if you’re not in a dispute, your IP posture should be built with litigation in mind. The strongest defenses come from proactive structure, not last‑minute scrambling.

How Ludwig Sees It

Ludwig, an IP law firm, views 2026’s litigation trends as a wake‑up call for companies that rely on innovation, brand strength, or proprietary processes. Much of our attention this year has focused on helping clients:

• Navigate the evolving boundaries of AI‑related IP rights
• Strengthen trademark enforcement programs to meet modern expectations
• Build patent strategies that anticipate eligibility challenges
• Implement trade secret frameworks that hold up under scrutiny
• Prepare for disputes before they escalate

Our perspective is shaped by real litigation experience. We’ve seen how courts analyze these issues, and we help clients build IP strategies that are practical, defensible, and aligned with business goals. The smart move is to prepare early so you’re not forced into reactive decisions when an issue arises.

Let’s Work Together: Global Experience, Personal Focus

Whether you’re evaluating AI’s impact on your IP, preparing for a product launch, responding to a threat letter, or trying to prevent a dispute, contact Ludwig APC at (619) 929‑0873 or consultation@ludwigiplaw.com to arrange a free, no‑strings‑attached consultation.

Frequently Asked Questions (FAQ)

1. What’s driving the biggest IP litigation changes in 2026?

AI adoption, trademark pressures, patent eligibility battles, and increased trade secret mobility.

2. Why is AI such a major factor in IP disputes?

Courts are defining how human contribution, training data, and AI‑generated outputs affect ownership and protection.

3. Are trademark disputes increasing?

Yes—digital confusion, brand dilution, and counterfeit activity are pushing companies toward more active enforcement.

4. What should businesses review before 2027?

Documentation practices, trademark monitoring, patent portfolio strength, and trade secret protection protocols.

5. How can Ludwig APC help?

We provide litigation‑ready IP strategy and proactive risk assessment shaped by real courtroom experience and decades of work with clients.

Few patent cases reach the Supreme Court, and even fewer reshape how pharmaceutical companies think about infringement risk. Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. is one of those rare matters drawing national attention. At its core is a deceptively simple question: when does a generic drugmaker “actively induce” infringement—and when is it simply following FDA rules?

Ludwig, an IP law firm, has followed this dispute closely because the Court’s answer carries major consequences for innovators and generics alike. Now that the June 2026 decision is settled, companies across the life sciences sector are reevaluating how they draft method‑of‑use patents, communicate about carved‑out indications, and prepare for future litigation.

Why this Is Newsworthy

The case centers on Vascepa, Amarin’s cardiovascular drug containing icosapent ethyl. After Amarin secured method‑of‑use patents for reducing cardiovascular risk, Hikma sought FDA approval to market a generic version—but only for the older, non‑patented indication. This is known as a skinny label strategy, where the generic omits patented uses to avoid infringement.

Amarin sued, arguing that Hikma’s label, website, press releases, and patient information collectively encouraged doctors to prescribe the drug for the patented cardiovascular indication. The district court dismissed the case, but the Federal Circuit revived it, which prompted Supreme Court review.

In June 2026, the Supreme Court issued a unanimous decision: Hikma did not actively induce infringement. The Court held that liability requires affirmative, active steps to encourage infringement—not vague statements, compliance language, or materials that merely coexist with a patented use.

How this Could Affect You

The Hikma decision highlights several lessons for companies navigating patent enforcement or defense:

• Skinny labels are still viable—but not risk‑free. The Court reaffirmed that generics can carve out patented uses, but brand‑name companies may still challenge surrounding communications. Every statement—press releases, websites, patient leaflets—must be evaluated for litigation exposure.
• Method‑of‑use patents require strategic drafting. The Court’s emphasis on “active steps” means patent owners must anticipate how generics might structure labels and communications. Clear claim language and strong technical support matter more than ever.
• Pharmaceutical marketing teams must coordinate with legal. Statements that seem harmless from a commercial perspective may be scrutinized in litigation. Cross‑functional review is essential.
• Litigation strategy must account for physician interpretation. The Federal Circuit revived the case partly because a doctor could interpret Hikma’s materials as encouraging the patented use. Even though the Supreme Court disagreed, the risk remains: ambiguity invites lawsuits.
• Prepare early so you don’t have to react later. Companies that proactively audit labeling, messaging, and patent portfolios are better positioned to avoid disputes—or win them should they arise.

How Ludwig Can Help

Ludwig views Hikma v. Amarin as a defining moment for pharmaceutical patent litigation. The decision clarifies the boundaries of induced infringement, but it also raises new strategic questions for both innovators and generics.

Our perspective is shaped by real patent and litigation experience. We’ve seen how courts analyze these issues, and we help clients build IP strategies that are practical, defensible, and aligned with business goals. The objective is clear: prepare now so you don’t have to react under pressure later.

Let’s Work Together: Global Experience, Personal Focus

Whether you’re evaluating how a Supreme Court ruling affects your patent portfolio, preparing for a product launch, responding to a threat letter, or trying to prevent a dispute before it escalates, contact Ludwig APC at (619) 929‑0873 or consultation@ludwigiplaw.com to arrange a free, no‑strings‑attached consultation.

Frequently Asked Questions

1. Why is Hikma v. Amarin drawing national attention?

Because it clarifies when generic drugmakers can be liable for inducing infringement—a major issue in pharmaceutical patent law.

2. What did the Supreme Court decide?

The Court unanimously held that Hikma did not actively induce infringement because its statements were not affirmative steps encouraging doctors to use the patented method.

3. How does this affect generic manufacturers?

It strengthens the viability of skinny labels, reducing litigation risk when generics carve out patented uses.

4. What should brand‑name companies learn from this?

Draft method‑of‑use patents strategically and monitor how generics communicate about carved‑out indications.

5. How can Ludwig APC Law help?

We provide litigation‑ready patent strategy, risk assessment, and guidance shaped by real courtroom experience and decades of experience with clients..